ArticleThe Journal of pharmacy and pharmacology2010

JS-K has potent anti-angiogenic activity in vitro and inhibits tumour angiogenesis in a multiple myeloma model in vivo.

Tanyel Kiziltepe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.